Clinical trial
Personalized Medicine for Canadians With Hemophilia: a Pragmatic Evaluation of the Web-Accessible Population Pharmacokinetics Service- Hemophilia (WAPPS-Hemo) Tailored Dosing.
NCT03615053 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Personalized Medicine for Canadians With Hemophilia: a Pragmatic Evaluation of the Web-Accessible Population Pharmacokinetics Service- Hemophilia (WAPPS-Hemo) Tailored Dosing.
- Lead sponsor
- McMaster University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 24, 2019
- Completion date
- September 30, 2023
- Enrollment
- 600 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.